Your privacy choices

Optional analytics are off unless you choose to allow them. They help us understand public page and button usage. Essential inquiry, order and security functions remain available.

Chat messages and form contents are not marketing analytics. Read our privacy notice.

Affiliate referrals

Referral attribution is a separate choice. Allow it to recognize the affiliate who introduced you, or turn it off to stop using referral cookies.

Skip to content
Raphael Pharmaceutical
About⌄
Company overviewLeadershipMedia & PublicationsNews & Press
Science⌄
Science & PipelineResearch AreasClinical Studies & ResultsEvidence & PublicationsPatents & IPScientific collaborations
RaphaWell⌄
Product overviewHow to useProduct FAQAvailability
Investors⌄
Company at a GlanceStock informationSEC filingsPresentationsGovernanceInvestor Relations contact
Partner With Us⌄
Strategic partnershipsAffiliate program
ContactSign In
Explore Raphael
About⌄
Company overviewLeadershipMedia & PublicationsNews & Press
Science⌄
Science & PipelineResearch AreasClinical Studies & ResultsEvidence & PublicationsPatents & IPScientific collaborations
RaphaWell⌄
Product overviewHow to useProduct FAQAvailability
Investors⌄
Company at a GlanceStock informationSEC filingsPresentationsGovernanceInvestor Relations contact
Partner With Us⌄
Strategic partnershipsAffiliate program
ContactSign In
Discover RaphaWell

Raphael Pharmaceutical

Reimagining research. Advancing possibilities.

Raphael Pharmaceutical is advancing cannabinoid science through translational research, disciplined evidence review and focused product development.

Explore our scienceMeet Raphael

Find your path

One company. Four ways to connect.

Raphael corporate and scientific imagery
01

Investors

Company information, public filings and investor resources.

Explore →
RaphaWell product packaging
02

Customers

Meet RaphaWell and ask our team about launch availability.

Explore →
Scientific collaboration imagery
03

Partners

Explore scientific, strategic and community collaboration.

Explore →
Raphael human wellness imagery
04

Affiliates

Learn about the pre-launch affiliate program.

Explore →

Company & leadership

Scientific focus, experienced leadership.

Raphael brings together corporate, scientific and research experience to explore the therapeutic potential of cannabinoid compounds.

About the companyMeet leadership
Raphael Pharmaceutical

An introduction to Raphael

Portrait of Shlomi Pilo, Chief Executive Officer of Raphael Pharmaceutical

Shlomi Pilo

Chief Executive Officer

Read biography →
Portrait of Uri Tadelis, Chief Financial Officer of Raphael Pharmaceutical

Uri Tadelis

Chief Financial Officer

Read biography →
Portrait of Dr. Igal Louria-Hayon, scientific leader at Raphael Pharmaceutical

Dr. Igal Louria-Hayon

Scientific leadership

Read biography →

Board & scientific contributors

Explore the wider documented team. Current advisory and Board appointments are identified where confirmation is pending.

Portrait of Zvi Laufer, Raphael Pharmaceutical board profile

Zvi Laufer

Board profile · role confirmation pending

Biography →
Portrait of Professor Joseph Press, scientific advisor to Raphael Pharmaceutical

Prof. Joseph Press, MD

Scientific advisor · status to confirm

Biography →
Portrait of Dr. Shachar Eduardo, scientific advisory profile for Raphael Pharmaceutical

Dr. Shachar Eduardo

Scientific advisory profile

Biography →
Portrait of Professor Alexandra Balbir-Gurman, scientific advisory profile for Raphael Pharmaceutical

Prof. Alexandra Balbir-Gurman

Scientific advisory profile

Biography →
Explore all leadership biographies →

RaphaWell

A simple daily routine, created with everyday wellness in mind.

RaphaWell combines CBG with sesame oil in an adult-use product. Explore the product, learn how to use it and ask our team about availability.

Discover RaphaWellAsk about availability
RaphaWell bottle and package

Media & publications

Research, company news and public records.

Explore recent publications, company announcements and the evidence behind our research.

Investor presentation replay · September 17, 2026

Raphael’s live Life Sciences Virtual Investor Forum presentation

Watch the management presentation and Q&A replay published by B2i Digital.

View source ↗

Peer-reviewed research · March 31, 2026

Cannabigerol modulates neutrophil activity in preclinical rheumatoid arthritis research

Read the indexed research record, methods and stated limitations.

View source ↗

Intellectual property · November 17, 2025

Raphael reports a provisional patent filing related to CBG research

Review the company-reported milestone in its intellectual-property context.

Read more →
View Media & Publications →
RAPHAELPHARMACEUTICAL

Science intelligence.
Greater possibilities.

Contact Raphael

About

LeadershipMedia & PublicationsNews & Press

Science

Research AreasClinical Studies & ResultsEvidence & PublicationsPatents & IPScientific collaborations

RaphaWell

How to useProduct FAQAvailability

Investors

Stock informationSEC filingsPresentationsGovernanceInvestor Relations contact

Partner With Us

Affiliate program

Policies

PrivacyTerms of useAffiliate termsAccessibility

© Raphael Pharmaceutical Inc.